NZ’s one-size-fits-all approach to managing type 2 diabetes is better in theory than practice for many patients.
- Associate Professor, Health Sciences, University of Waikato
Mattel’s new Barbie comes equipped with an insulin pump and wears a continuous glucose monitor on her arm.
Type 2 diabetes is more aggressive in young people, harder to manage and more likely to lead to a premature death.
To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that happens, newly-funded health technologies won’t get to those most in need.
In a controversial move in 2021, drug-funding agency Pharmac fully subsidised new diabetes drugs for Māori and Pacific patients. Could the result help set a precedent?
Contact Lynne for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Hamilton, New Zealand
- Article Feed
- ORCID
- Joined
